In the simulations, an apical or basolateral membrane model is placed into a rectangular cuboid box containing water molecules
4:389-398 (2013) Hajar-Azhari S, Wan-Mohtar W, Ab Kadir S, Rahim MHA, Saari N
A clinical study following people with CF on elexacaftor/tezacaftor/ivacaftor (ETI) for 6 months found a significant reduction in antibiotic use by the end of the studysuggesting a lower prevalence of bacterial-induced exacerbations (Nichols et al., 2022)
Yes, GLP-1 medications may lead to muscle and bone mass loss, especially in older adults (over 65) and those using them for cosmetic reasons
Semaglutide GLP-1 works by reducing appetite, improving blood sugar control, and promoting feelings of fullness, which helps people eat less and make healthier food choices
Linagliptin, on the other hand, metabolizes through a different pathway, and the majority of the drug is excreted in a non-renal way compared to the others